The European Union has began its mass vaccination programme after distributing its first batch of the Pfizer/Biontech vaccine to member states.
The next vaccine set for approval by the EU is the Moderna vaccine, with authorisation expected on January 6th.
Following that, the Oxford/AstraZeneca vaccine, which is considerably easier to administer as it does not require very cold storage as is the case with the Pfizer-BioNTech and Moderna jabs, is expected to get EU approval in early January.
However, it has been reported that the UK regulator could approve the Oxford/AstraZeneca jab within days.
AstraZeneca chief Pascal Soriot told the Sunday Times he believed researchers had found the “winning formula” using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days.